Re: 'Use of androgen deprivation therapy in prostate cancer: indications and prevalence' by Connolly et al.
Bo-Eric
BE
Persson
D000726:Androgen Antagonists / Q000009:adverse effects* / Q000627:therapeutic use*; D018450:Disease Progression; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000726:Androgen Antagonists